Surge in Cardiovascular Ailments Augments Uptake of D-dimer Testing, Says TMR

The leading players operating in the global D-dimer testing market are Siemens Healthcare, Alere, Inc., and Abbott Laboratories. The cumulative share of these companies stood at 49.9% in 2013. The progress of these players will primarily depend on the intensifying research and development activities. Analysts anticipate that the highly fragmented market will witness a large number of new entrants in the coming years, making their way in the market with technologically advanced and user-friendly testing solutions.

The research report states that the opportunity in the global D-dimer testing market will be worth US$1.9 bn by 2022. The overall market is anticipated to be driven by the deep vein thrombosis as the segment progresses at a CAGR of 2.7% from 2014 to 2022. In terms of geography, the D-dimer testing methods will witness an increased adoption in North America driving the region to contribute nearly US$917.1 mn by 2022. A strong presence of the point of care testing methods and laboratory-based D-dimer tests will provide a boost to this market in North America in the coming years.

Download Free exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2398

High Prevalence of CVD Drives Uptake of D-dimer Testing Methods

The high incidence of cardiovascular diseases (CVD) is likely to be the prime cause of increasing demand for D-dimer testing methods in the near future. Effective disease management will require improved indicators, which will minimize the cost of treating cardiovascular diseases, strokes, and attacks. Thus, players in the D-dimer market are focusing on developing tests that will help in early diagnosis of CVD, an effort that will pick up the pace in the coming years.

The global D-dimer testing market is also being driven by increasing number of deep vein thrombosis patients being treated through anti-coagulation therapy. Patients suffering from cerebral artery disease or coronary disease also require this therapy, which had led to a rise in the demand for coagulometers and related reagents. Owing to this reason, several patients require point of care (POC) testing to ensure they corroborate with central coagulation laboratory results.

Inaccuracy of POC Challenges Market Growth

Despite the strong market drivers, the global D-dimer testing market is being held back due to the discrepancies in interpreting D-dimer values as the values naturally increase for the elderly, thereby decreasing its accuracy for embolism. However, overcoming this restraint by designing age-adjusted D-dimer testing models to eliminate DVT and pulmonary embolism (PE) has created a new opportunity for the manufacturers in the global market.

The lack of acceptance of D-dimer testing for point of care testing is a tough challenge for this market. Health care providers are still skeptical towards accepting D-dimer testing as a valid method of testing due to the inaccuracy in results as compared to laboratory testing. Thus, its usefulness in clinics, convenience, and cost of higher adoption still remains under question.

“Players need to focus on bioinformatics and integrated software for precise multiple factor analysis all throughout standardized runs,” states the lead author of research report. Furthermore, it would also ensure quality control in the longer-run. Manufacturers must also focus on implementing rapid diagnostic testing to solve the issue of overcrowding in emergency departments, which has become a threat to the public health. Identifying the popularly used tests, improving their levels of accuracy in POC testing methods, and narrowing down on their impact on the patient outcomes will revolutionize the management of overcrowding in emergency departments. This, in turn, will help avert unnecessary cost of laboratory services and spread of diseases.

The aforementioned review is based on Transparency Market Research’s report, titled “D-dimer Testing Market - Global Industry Analysis, Size, Share, Volume, Growth, Trends and Forecast 2014 – 2022.”

The global D-dimer Testing Market is segmented as follows:

Global D-dimer Testing Market Revenue (USD Million) and Volume (Number of Tests), by Testing Method
Point-of-Care Tests
Laboratory Tests
Coagulation Analyzers
Clinical Chemistry Analyzers
Global D-dimer Testing Market Revenue (USD Million) and Volume (Number of Tests), by Applications
Deep Vein Thrombosis
Pulmonary Embolism
Disseminated Intravascular Coagulation
Global D-dimer Testing Market Revenue (USD Million) and Volume (Number of Tests), by Geography
North America
U.S.
Canada
Europe
Germany
U.K.
Rest of Europe
Asia Pacific
Japan
China
Rest of Asia Pacific
Latin America (LATAM)
Brazil
Mexico
Rest of Latin America
Middle East and North Africa (MENA)
Saudi Arabia
United Arab Emirates (U.A.E)
Rest of MENA
Rest of the World (RoW)

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.